Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $13.75B | $13.64B | +0.80% |
Cost of Revenue | $3.04B | $3.1B | -1.78% |
Operating Income | $4.71B | $-1.68B | +380.75% |
Net Income | $3.27B | $-2.56B | +228.13% |
EPS (Basic) | $2.63 | $-2.05 | +228.29% |
EPS (Diluted) | $2.61 | $-2.05 | +227.32% |
SG&A Expense | $2.62B | $2.75B | -4.69% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $55.72B | $53.58B | +4.00% |
Current Assets | $14.72B | $12.32B | +19.49% |
Current Liabilities | $11.19B | $10.78B | +3.78% |
Stockholders' Equity | $19.67B | $18.28B | +7.62% |
Long-Term Debt | $24.95B | $23.35B | +6.84% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $2.58B | $3.54B | -27.09% |
Investing Cash Flow | $-2.53B | $-2.51B | -0.68% |
Financing Cash Flow | $-4.99B | $-4.31B | -15.74% |
Dividends Paid | $2B | $1.96B | +2.14% |
Share Buybacks | $1.26B | $500M | +151.40% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 34.3% | -12.3% | +46.57% |
Net Margin | 23.8% | — | — |
ROE | 16.6% | — | — |
ROA | 5.9% | — | — |
Current Ratio | $1.315 | — | — |
Other companies in Biotechnology